Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Leerink Swann weighs in on Questcor Pharmaceuticals (QCOR +9.6%) after Medicaid's bump-up in...

  • Tuesday, September 4, 2012, 1:51 PM ET
    Leerink Swann weighs in on Questcor Pharmaceuticals (QCOR +9.6%) after Medicaid's bump-up in reimbursement rates, upping its revenue projection on the company to $675M from $626M and its EPS estimates from $3.67 to $4.21.
Track new comments on this story

This news story has 1 comment:

  •  
    Today's action and market reaction bodes well for QCOR and all of us who stayed strong long throughout the recent bout with the shorts. There is and will continue to be a short squeeze as a background to a well positioned company with an impeccable corporate model.
    4 Sep 2012, 04:46 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »